Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 7, November

TGF Beta Inhibition for Cancer Therapy

Volume:6   Issue: 7
Pp: 565-578
Elise F. Saunier and Rosemary J. Akhurst
DOI: 10.2174/156800906778742460
Published on: 01 March, 2012

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

Volume:6   Issue: 7
Pp: 603-612
J. G. Hengstler, E. O. Bockamp, M. Hermes, M. Brulport, A. Bauer, W. Schormann, I. B. Schiffer, C. Hausherr, L. Eshkind, C. Antunes, A. Franzen, K. Krishnamurthi, E. Lausch, R. Lessig, T. Chakrabarti, D. Prawitt, B. Zabel and C. Spangenberg
DOI: 10.2174/156800906778742488
Published on: 01 March, 2012

Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention

Volume:6   Issue: 7
Pp: 613-622
Xiaoxin Chen, Sandeep Sood, Chung S. Yang, Ning Li and Zheng Sun
DOI: 10.2174/156800906778742451
Published on: 01 March, 2012

Protein Kinases as Drug Targets in Cancer

Volume:6   Issue: 7
Pp: 623-634
Mehmet Alper Arslan, Ozgur Kutuk and Huveyda Basaga
DOI: 10.2174/156800906778742479
Published on: 01 March, 2012

Adrenomedullin: A Tumor Progression Factor via Angiogenic Control

Volume:6   Issue: 7
Pp: 635-643
Misa Nakamura, Bo Han, Osamu Nunobiki and Kennichi Kakudo
DOI: 10.2174/156800906778742442
Published on: 01 March, 2012